Ramius Advisors’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-175,169
Closed -$1.77M 267
2021
Q4
$1.77M Buy
175,169
+121,100
+224% +$1.22M 0.62% 26
2021
Q3
$541K Hold
54,069
0.32% 59
2021
Q2
$539K Sell
54,069
-218,575
-80% -$2.19M 0.2% 77
2021
Q1
$2.7M Buy
+272,644
New +$2.77M 0.72% 42

Other funds holding EQHA.U

Ramius Advisors's EQHA.U Position: Q1 2022 in Review

Ramius Advisors sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q1 2022, closing a stake of 175,169 shares — an estimated $1.77M sold.

Ramius Advisors first reported a position in EQHA.U in Q1 2021 and held it in 4 quarters. The position peaked at $2.7M in Q1 2021. 17 funds tracked by Wall St. Rank hold EQHA.U as of Q1 2022.

  • Ramius Advisors reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
  • Ramius Advisors sold 175,169 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q1 2022, an estimated $1.77M.
  • Ramius Advisors first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 4 quarters.
  • Ramius Advisors's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $2.7M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q1 2022.

Based on Ramius Advisors's 13F filing for Q1 2022, filed 16 May 2022.